Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approach

Cure rates for primary mediastinal large B-cell lymphoma (PMBCL) have improved with the integration of rituximab. However, the type of primary therapy and role of radiotherapy (RT) remains ill-defined. Herein, we evaluated the outcome of PMBCL primarily treated with rituximab, cyclophosphamide, doxo...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Blood Ročník 136; číslo 24; s. 2803
Hlavní autori:	Hayden, Anna R, Tonseth, Petter, Lee, Derrick G, Villa, Diego, Gerrie, Alina S, Scott, David W, Freeman, Ciara L, Slack, Graham W, Farinha, Pedro, Skinnider, Brian, Yenson, Paul R, Benard, Francois, Lo, Andrea, Pickles, Tom, Wilson, Donald, Connors, Joseph M, Sehn, Laurie H, Savage, Kerry J
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 10.12.2020
Predmet:	Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - administration & dosage Cyclophosphamide - administration & dosage Disease-Free Survival Doxorubicin - administration & dosage Female Follow-Up Studies Humans Lymphoma, Large B-Cell, Diffuse - diagnostic imaging Lymphoma, Large B-Cell, Diffuse - drug therapy Lymphoma, Large B-Cell, Diffuse - mortality Male Mediastinal Neoplasms - diagnostic imaging Mediastinal Neoplasms - drug therapy Mediastinal Neoplasms - mortality Middle Aged Positron-Emission Tomography Prednisone - administration & dosage Rituximab - administration & dosage Survival Rate Vincristine - administration & dosage
ISSN:	1528-0020, 1528-0020
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!